Loopback Analytics Teams Up with Loma Linda University Health to Enhance Specialty Pharmacy Services

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DALLAS, July 24, 2024 /PRNewswire/ — Loopback Analytics, a leading provider of data analytics and market access services for health systems’ specialty pharmacy programs, is pleased to announce its collaboration with Loma Linda University Health, a comprehensive academic healthcare system, to enhance their specialty pharmacy services.

In today’s rapidly evolving healthcare landscape, specialty pharmacies are integral in utilizing resources that improve patient access and overall patient care. By taking a data-driven approach, pharmacy leaders are uniquely equipped to navigate the complexities of modern healthcare access, enhancing the positive impact on patients.

“Loopback is thrilled to be providing cutting-edge technology to a nationally regarded academic health system like Loma Linda University Health,” said Neil Smiley, Loopback Analytics CEO. “This collaboration represents a significant step in advancing our commitment to supporting and empowering health system specialty pharmacies to deliver exceptional patient outcomes and access to life-saving medications.”

CisionCision View original content to download multimedia:https://www.prnewswire.com/news-releases/loopback-analytics-teams-up-with-loma-linda-university-health-to-enhance-specialty-pharmacy-services-302205517.html

SOURCE Loopback Analytics

Staff

Recent Posts

Hemostemix Closes $469,366 Private Placement

Calgary, Alberta--(Newsfile Corp. - July 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

15 minutes ago

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr.…

15 minutes ago

Virbac : Declaration of the number of shares and voting rights 06/2025

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of…

15 minutes ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC…

15 minutes ago

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of…

16 minutes ago